Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
daisies
AddedFeb 17, 2024
UpdatedJun 18, 2026
daisies

daisies

Pre-Seed

Daisies: A comprehensive telemedicine platform for women's health, offering nutrition, psychology, gynecology, and skincare.

HQ
Del Mar, CA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Daisies is a telemedicine platform founded to address women's health comprehensively. Its core mission is to empower women to prioritize their health by providing accessible and affordable healthcare services. The platform offers a subscription-based model that includes consultations in nutrition, psychology, gynecology, and skincare. Daisies aims to eliminate barriers such as time, cost, and location, ensuring that women can take control of their health conveniently.

Notable affiliated individuals include a team of female healthcare professionals dedicated to women's wellness. Daisies has attracted attention for its holistic approach and user-friendly interface, making significant strides in the telemedicine sector. The platform's impact is reflected in its growing user base and positive feedback from patients who appreciate the comprehensive care model. Investors have shown interest due to its innovative approach and potential for scalability in the digital health market.

daisies - Similar Companies

Kiira logo

Kiira

kiira.io

Jessie logo

Jessie

TruDiary logo

TruDiary

Rosy Wellness logo

Rosy Wellness

meetrosy.com

Well-Kept Beauty logo

Well-Kept Beauty

wellkeptbeauty.com

LunaJoy logo

LunaJoy

hellolunajoy.com

WellMiss logo

WellMiss

hellowellmiss.com

Wingwomen logo

Wingwomen

mywingwomen.com

Clinikally logo

Clinikally

clinikally.com

Tia logo

Tia

asktia.com

Alpha Medical logo

Alpha Medical

helloalpha.com

Dapper Care logo

Dapper Care

dapper.care

BabyLiveAdvice logo

BabyLiveAdvice

babyliveadvice.com

Between logo

Between

between.health

Dear Doc Singapore logo

Dear Doc Singapore

dear-doc.com

daisies - Quick Facts

Who are daisies' competitors?

Companies similar to daisies include Kiira, Jessie, TruDiary and Rosy Wellness.

When was daisies founded?

daisies was founded in 2021.

Where is daisies' headquarters located?

daisies' headquarters is located in Del Mar, CA, US.

When was daisies' last funding round?

daisies' most recent funding round was for $50k (USD) in October 2022.

How much has daisies raised to-date?

As of Oct 31, 2022, daisies has raised a total of $50k (USD).

How many employees does daisies have?

daisies has 28 employees as of Feb 4, 2024.

daisies - Classification

Ownership
  • Private
Technology
  • Telemedicine
Geographic Exposure
  • Latin America
Model
  • Platform
Revenue
  • Recurring
  • SaaS
Customer
  • Consumers
Main Product
  • Telemedicine
  • Womens Health
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified